Back to 
Candriam S.C.A.
Candriam S.C.A.
BCRX2 quarters
Position history for Candriam S.C.A.'s holdings in BIOCRYST PHARMACEUTICALS INC
Candriam S.C.A. holds 2.5M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $25.1M as of 2026-Q2. The position was increased (+10.0% shares). BCRX represents 0.1% of Candriam S.C.A.'s portfolio.
Current Value
$25.1M
Current Shares
2.5M
Total Value Change
+$3.4M
Total Shares Change
+228,108
Quarter-by-Quarter History
Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP